Braveman BioMed Consultants LLC

Following is a sampling of published articles and presentations relevant to the mission of BBMC. Copies of some unpublished presentations/seminars are available on request.

Clinical Trials:

Braveman, N. S. & Michalowicz, B. Phase III Pivotal Clinical Trials: Clinical Decision-making. In Giannoble, W., Genco, R., & Burt, B (Eds). Principles of Clinical Oral Health Research. Wiley-Blackwell, 2010, 213-246.

Health in Underrepresented Minority Populations:

Legeros, R. and Braveman, N. (Eds).  Minority Oral Health. The Dental Clinics of North America, 47, (2002).

Braveman, N.S. Building an effective research infrastructure to meet the oral health needs of the Hispanic community.  Supplement: Compendium of Continuing Education in Dentistry, 23 (2002), 46-47.

Science Program Analysis and Planning:

Braveman, N.S.  Development of health promoting behaviors. In W. Mouradian, A. Porter, C. Keegan, and K. Cantillon (Eds.) Promoting Oral Health Of Children With Neurodevelopmental Disabilities and Other Special Needs: Proceedings of A Meeting to Develop Training and Research Agendas. May 4-5, 2001, 116-123.

Braveman, N.S.  The use and safety of dental amalgam:  An overview of research and a proposed research agenda.  In I.A. Mjor & G. N. Pakhomov (Eds.) Dental Amalgam and Alternative Direct Restorative Materials. Geneva, Switzerland: World Health Organization, 1997, 149-169.

 Science Program Evaluation:

Braveman, N.S.  What science indicators can tell policymakers.  In Margaret O. Meredith, Stephen D. Nelson and Albert H. Teich (Eds.) Science and Technology Yearbook: 1991.  Washington, D.C.: American Association for the Advancement of Science, 267-278.

Braveman, N.S.  Evaluation at NIH: The policy issues.  In Susan L. Sauer (Ed.) R & D in FY 1989: Looking Ahead in an Election Year.  Washington, D.C.:  American Association for the Advancement of Science, 1988.

Vener, K.J. & Calkins, B. M.  Analysis of SBIR phase I and phase II review results at the National Institutes of Health. FASEB J. 1991, 5, 2640-2644. (As Acting Director of NIH's Division of Planning and Evaluation, Dr. Braveman provided funding, oversight and guidance in all phases of this study).

The Jawbone's Connected to the Hip Bone: Interdisciplinary Research in the 21^st Century. Keynote Address: Florida State University School of Medicine, March, 2008.

The Future of Dental Research: A Framework for Strategic Planning. Keynote Address. University of Florida School of Dentistry, November, 2002.

Developmental Aspects of Health Promotion:  Where Does Health Promoting Behavior Come From? LEND Conference, Seattle, Washington. May, 2001.

Opportunities for Scientific Collaboration Among Oral Health Scientists in the Middle East. Bridge to Peace International Dental Conference, Jerusalem, Israel, May 30, 1997.

Statisticians' Roles In Clinical Trials: A View From Peer Review. Society of Clinical Trials Research. Washington, DC, May 14, 2002.

Monitoring Clinical Trials: What You Do Matters. Seminar at The University of California, San Francisco, May 20, 2002.  

Clinical Trials Research: Design and Ethical Considerations.  One week seminar presented at Summer Research Institute on Clinical Trials, University of Washington, Seattle, Washington.  Annually between August, 1995 and 2001.